News Daily News Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT L.A. McKeown December 05, 2024
News Features GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix? Todd Neale November 13, 2024
News Conference News HFSA 2024 ‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM L.A. McKeown October 02, 2024
News Conference News HFSA 2024 FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone? Michael O'Riordan October 02, 2024
News Daily News Yes, Clinical Inertia IS the Leading Cause of GDMT Underuse in HFrEF Todd Neale September 20, 2024
News Conference News ESC 2024 FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients Michael O'Riordan September 01, 2024
News Conference News ESC 2024 Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD Todd Neale September 01, 2024
News Daily News Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors Yael L. Maxwell August 15, 2024
News Daily News Scoring System Puts Focus on Medical Therapy Optimization in HFrEF L.A. McKeown August 13, 2024
News Daily News Acute HF Patients Live Longer When Seen by Specialists Michael O'Riordan August 09, 2024
News Daily News Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA L.A. McKeown July 02, 2024
News Daily News Kidney Events High in Older Patients After HF Hospitalization L.A. McKeown May 30, 2024
News Conference News ESC Heart Failure 2024 Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show Michael O'Riordan May 21, 2024
News Conference News ESC Heart Failure 2024 SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM Michael O'Riordan May 13, 2024
News Conference News ESC Heart Failure 2024 Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF Michael O'Riordan May 12, 2024
News Daily News New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise Yael L. Maxwell May 08, 2024